We spoke to Dr Toon Wei Lim (National University Hospital, Singapore) about the findings from the GARFIELD-AF and ORBIT-AF registry studies studying patients with atrial fibrillation (AF), as well as the key predictors of intracranial haemorrhage in patients with AF. He also highlights his recommendations for how these findings might be translated into clinical practice in the routine management of patients with AF.
Speaker’s Disclosures: Toon Wei Lim has received research support from Bayer, Boehringer-Ingelheim, and Pfizer.
Questions:
1. Considering the findings from the GARFIELD-AF and ORBIT-AF registry studies, what are the key predictors of intracranial haemorrhage in patients with atrial fibrillation? (0:05)
2. How would you recommend that these findings are implemented in routine management of patients with atrial fibrillation? (0:51)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with the Arrhythmia Alliance (A-A) at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
